All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| ENTA / Enanta Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| KRON / Kronos Bio, Inc.
|
|
|
|
|
|
|
|
| NSPR / InspireMD, Inc.
|
|
|
|
|
|
|
|
| SWTX / SpringWorks Therapeutics, Inc.
|
|
|
|
|
|
|
|
| KPRX / Kiora Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| PRQR / ProQR Therapeutics N.V.
|
|
|
|
|
|
|
|
| TRML / Tourmaline Bio, Inc.
|
|
|
|
|
|
|
|
| TELA / TELA Bio, Inc.
|
|
|
|
|
|
|
|
| ZVRA / Zevra Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TERN / Terns Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| PMVP / PMV Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| HRTX / Heron Therapeutics, Inc.
|
|
|
|
|
|
|
|
| FDMT / 4D Molecular Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CRBP / Corbus Pharmaceuticals Holdings, Inc.
|
|
|
|
|
|
|
|
| GOSS / Gossamer Bio, Inc.
|
|
|
|
|
|
|
|
| LQDA / Liquidia Corporation
|
|
|
|
|
|
|
|
| KURA / Kura Oncology, Inc.
|
|
|
|
|
|
|
|
| OPTN / OptiNose, Inc.
|
|
|
|
|
|
|
|
| SKYE / Skye Bioscience, Inc.
|
|
|
|
|
|
|
|
| XBI / SPDR Series Trust - SPDR S&P Biotech ETF Call
|
|
|
|
|
|
|
|
| VTYX / Ventyx Biosciences, Inc.
|
|
|
|
|
|
|
|
| REPL / Replimune Group, Inc.
|
|
|
|
|
|
|
|
| CTMX / CytomX Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ELEV / Elevation Oncology, Inc.
|
|
|
|
|
|
|
|
| PRAX / Praxis Precision Medicines, Inc.
|
|
|
|
|
|
|
|
| STRO / Sutro Biopharma, Inc.
|
|
|
|
|
|
|
|
| AVTX / Avalo Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BOLT / Bolt Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| SCPH / scPharmaceuticals Inc.
|
|
|
|
|
|
|
|
| COLL / Collegium Pharmaceutical, Inc.
|
|
|
|
|
|
|
|
| KPTI / Karyopharm Therapeutics Inc.
|
|
|
|
|
|
|
|
| COCP / Cocrystal Pharma, Inc.
|
|
|
|
|
|
|
|
| RGLS / Regulus Therapeutics Inc.
|
|
|
|
|
|
|
|
| CNTX / Context Therapeutics Inc.
|
|
|
|
|
|
|
|
| WVE / Wave Life Sciences Ltd.
|
|
|
|
|
|
|
|
| FGEN / FibroGen, Inc.
|
|
|
|
|
|
|
|
| VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| GERN / Geron Corporation
|
|
|
|
|
|
|
|
| TARA / Protara Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NRIX / Nurix Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CATX / Perspective Therapeutics, Inc.
|
|
|
|
|
|
|
|
| OVID / Ovid Therapeutics Inc.
|
|
|
|
|
|
|
|
| ACRS / Aclaris Therapeutics, Inc.
|
|
|
|
|
|
|
|
| RZLT / Rezolute, Inc.
|
|
|
|
|
|
|
|
| ELDN / Eledon Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| TENX / Tenax Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NXTC / NextCure, Inc.
|
|
|
|
|
|
|
|
| ALEC / Alector, Inc.
|
|
|
|
|
|
|
|
| JSPR / Jasper Therapeutics, Inc.
|
|
|
|
|
|
|
|
| LRMR / Larimar Therapeutics, Inc.
|
|
|
|
|
|
|
|
